- Home
- RVMD vs OBDC Comparison
RVMD vs OBDC Comparison
Compare RVMD & OBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- OBDC
- Stock Information
- Founded
- RVMD 2014
- OBDC 2015
- Country
- RVMD United States
- OBDC United States
- Employees
- RVMD N/A
- OBDC N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- OBDC Investment Managers
- Sector
- RVMD Health Care
- OBDC Finance
- Exchange
- RVMD Nasdaq
- OBDC Nasdaq
- Market Cap
- RVMD 7.5B
- OBDC 7.5B
- IPO Year
- RVMD 2020
- OBDC 2019
- Fundamental
- Price
- RVMD $36.63
- OBDC $14.12
- Analyst Decision
- RVMD Strong Buy
- OBDC Buy
- Analyst Count
- RVMD 12
- OBDC 8
- Target Price
- RVMD $69.50
- OBDC $15.50
- AVG Volume (30 Days)
- RVMD 1.5M
- OBDC 2.7M
- Earning Date
- RVMD 08-06-2025
- OBDC 08-06-2025
- Dividend Yield
- RVMD N/A
- OBDC 11.98%
- EPS Growth
- RVMD N/A
- OBDC N/A
- EPS
- RVMD N/A
- OBDC 1.57
- Revenue
- RVMD N/A
- OBDC $1,661,827,000.00
- Revenue This Year
- RVMD N/A
- OBDC $21.06
- Revenue Next Year
- RVMD $234.26
- OBDC N/A
- P/E Ratio
- RVMD N/A
- OBDC $8.97
- Revenue Growth
- RVMD N/A
- OBDC 3.60
- 52 Week Low
- RVMD $29.17
- OBDC $12.11
- 52 Week High
- RVMD $62.40
- OBDC $15.73
- Technical
- Relative Strength Index (RSI)
- RVMD 51.68
- OBDC 35.82
- Support Level
- RVMD $36.20
- OBDC $13.92
- Resistance Level
- RVMD $38.60
- OBDC $15.01
- Average True Range (ATR)
- RVMD 1.25
- OBDC 0.22
- MACD
- RVMD 0.09
- OBDC -0.09
- Stochastic Oscillator
- RVMD 56.43
- OBDC 16.71
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About OBDC Blue Owl Capital Corporation
Blue Owl Capital Corp is a specialty finance company and business development company (BDC) focused on providing direct lending solutions to U.S. middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns, including senior secured, subordinated, or mezzanine loans and equity-related instruments. Its investment strategies are intended to generate favorable returns across credit cycles with an emphasis on preserving capital.